Deals Rumor Mill: Pfizer, Sprint, AT&T
Pharma powerhouse Pfizer Inc. could increase its bid for British rival AstraZeneca PLC to $106 billion, including a greater cash consideration, sources told Bloomberg on Thursday. The revised bid could come...To view the full article, register now.
Already a subscriber? Click here to view full article